Arkadios Wealth Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-137
Closed -$6K 726
2021
Q3
$6K Sell
137
-361
-72% -$17.6K ﹤0.01% 1548
2021
Q2
$24K Buy
498
+436
+703% +$20.8K ﹤0.01% 1199
2021
Q1
$2K Sell
62
-93
-60% -$4.41K ﹤0.01% 1503
2020
Q4
$7K Buy
+155
New +$7.03K ﹤0.01% 1036
2020
Q2
Sell
-74
Closed -$2.67K 968
2020
Q1
$2.67K Buy
+74
New +$2.95K ﹤0.01% 894

Other funds holding BME

Arkadios Wealth Advisors's BME Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of BlackRock Health Sciences Trust (BME) in Q4 2021, closing a stake of 137 shares — an estimated $6K sold.

Arkadios Wealth Advisors first reported a position in BME in Q1 2020 and held it in 5 quarters. The position peaked at $24K in Q2 2021. 60 funds tracked by Wall St. Rank hold BME as of Q4 2021.

  • Arkadios Wealth Advisors reported no remaining BlackRock Health Sciences Trust position as of Q4 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 137 BlackRock Health Sciences Trust shares in Q4 2021, an estimated $6K.
  • Arkadios Wealth Advisors first reported a position in BlackRock Health Sciences Trust in Q1 2020 and held it in 5 quarters.
  • Arkadios Wealth Advisors's BlackRock Health Sciences Trust position peaked at $24K in Q2 2021.
  • 60 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.